Table 1.
Calcium imaging experiments
Drug | Cells nr. | Mean % | SD % | S.L. |
---|---|---|---|---|
l-AP4 | 429 | 88 | 7 | *** |
l-SOP | 253 | 91 | 6 | *** |
l-glutamic acid | 213 | 89 | 8 | *** |
MPPG/L-AP4 | 30 | 100 | 1 | |
MSOP-L-AP4 | 16 | 96 | 5 | |
MPPG/L-SOP | 12 | 100 | 1 | |
MSOP/L-SOP | 11 | 98 | 5 | |
MPPG/Glu | 34 | 99 | 1 | |
MSOP/Glu | 23 | 99 | 1 | |
MPPG | 19 | 104 | 1 | |
MSOP | 21 | 107 | 3 | * |
8-Br-cAMP/l-AP4 | 38 | 93 | 3 | ** |
8-Br-cAMP/Glu | 21 | 92 | 2 | * |
8-Br-cAMP/l-SOP | 10 | 93 | 1 | * |
8-Br-cAMP | 38 | 100 | 3 | |
DB-cAMP/l-AP4 | 14 | 92 | 1 | ** |
DB-cAMP | 14 | 100 | 2 | |
H-7 | 4 | 100 | 4 | |
NMDA | 33 | 100 | 4 | |
l-CCG-I | 49 | 98 | 4 | |
Kainic acid | 71 | 100 | 4 | |
l-Quisqualic acid | 38 | 100 | 4 | |
AMPA | 19 | 100 | 4 | |
S-CHPG | 15 | 100 | 4 | |
t-ADA | 25 | 100 | 4 | |
ECS | 21 | 100 | 1 | |
ECS ([K+], 40 mM) | 3 | 100 | 1 | |
ECS ([Co2+], 4 mM) | 48 | 57 | 13 | *** |
ECS ([Ca2+], 0 mM) | 59 | 82 | 8 | ** |
Nifedipine | 16 | 85 | 6 | ** |
Bay K 8644 | 22 | 108 | 1 | * |
Significance levels (S.L.): ∗∗∗, 0.1%; ∗∗, 1%; ∗, 5%. No symbol, not significantly different from control.